Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Cash Flows

v3.24.2.u1
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net loss for the period $ (25,125) $ (7,997)
Items not affecting cash:    
Stock based compensation 649 519
Net realizable value adjustments 1,339 5,826
Amortization of mineral properties 38 624
Depreciation of capital assets 1,255 973
Accretion expense 287 247
Amortization of deferred loan costs 33 22
Provision for reclamation (6) 0
Mark to market gain (1,474) (3,061)
Gain on sale of assets 2 0
Unrealized foreign exchange lgain (16) (316)
Changes in non-cash working capital:    
Trade receivables (29) 0
Lease receivable (570) 0
Inventory (3,842) (2,198)
Prepaid expenses (21) (183)
Accounts payable and accrued liabilities 1,846 582
Cash provided by used in operating activities (25,638) (4,962)
Investing activities    
Purchase of capital assets (1,853) (1,186)
Cash provided by used in investing activities (1,853) (1,186)
Financing activities    
Issuance of common shares for cash 26,646 46,637
Share issue costs (806) (3,002)
Proceeds from exercise of warrants and stock options 11,351 297
Repayment of debt (5,813) (2,666)
Cash provided by used in financing activities 31,378 41,266
Effects of foreign exchange rate changes on cash (65) 23
Increase in cash, cash equivalents, and restricted cash 3,822 35,141
Beginning cash, cash equivalents, and restricted cash 68,249 41,140
Ending cash, cash equivalents, and restricted cash $ 72,071 $ 76,281